The effect of hemodiafiltration with on-line endogenous reinfusion (on-line HFR) on anemia: Design of a European, open, randomised, multicentre trial

Journal of Nephrology

Volumn 13, Issue 1, 2000, Pages 34-42

  Cerulli, N ^a   La Greca, G ^a   Laville, M ^a,a   Palla, R ^a,a   Ramello, A ^a   Ghezzi, P M ^a   Fouque, D ^a,a   Pizzarelli, F ^a,a   Schena, Fp ^a   Tetta, C ^a,g   Buades, J ^a   Camussi, G ^a   David, S ^a   Hoerl, W ^a   Triolo, G ^a   Maggiore, U ^a   Chiarulli, G ^a   Losurdo, N ^a   Petrarulo, F ^a   Sacchetti, A ^a   Pallotta, G ^a   Dagostino, F ^a   Del Mastro, G ^a   Sasdelli, M ^a   Mura, C ^a   Bongiorno, P ^a   Grill, A ^a   Varvara, M ^b   Carabellese, S ^c   Laraia, E ^d   Rizzi, R ^a   Mancini, A ^a   Losappio, R ^a   Maiorca, R ^a   Movilli, E ^a   Scolari, F ^a   Fiorini, F ^a   Imperatore, P ^a   Ranieri, F ^a   Bozzi, M ^a   Cuzzola, R ^a   De Min, A ^a   Specchio, A ^a   Bonomini, M ^a   Cuonzo, Mt ^a   Di Bari, M ^a   Dogliani, M ^a   Fidelio, T ^a   Meinero, S ^a   Canepari, G ^a   Surian, M ^a   Bonforte, G ^a   Rivera, R ^a   Sangalli, L ^a   Broccoli, R ^a   Maggiore, Q ^a   Cavatorta, F ^a   Zollo, A ^a   Mastrangelo, F ^a   De Blasi, V ^a   Alfonso, L ^a   Usberti, M ^a   Rondina, M ^a   Combarnous, F ^a   Basile, C ^a   Giordano, R ^a   Betti, G ^a   Lopez, T ^a   Casino, F ^a   Ponticelli, C ^e   Valenti, G ^e   Ambroso, G ^e   Como, G ^e   Barbiano Di Belgioioso, G ^f   Bertoli, S ^f   Buzzi, L ^f   Albertazzi, A ^a   Lucchi, L ^a   Virgilio, M ^a   Giancaspro, V ^a   Pastore, G ^a   Conversano, A ^a   Testa, A ^a   Malcangi, U ^a   Reina, E ^a   Rusconi, L ^a   Meterangelis, A ^a   Amato, M ^a   Campolo, G ^a   Giachino, G ^a   Chiappero, F ^a   Carozzi, S ^a   Schelotto, C ^a   Sanna, A ^a   more..

^a Villa Luce Clinic ^*

^b Villa Luce Clinic   (Italy)

^c S Rita Clinic   (Italy)

^d II Div   (Italy)

^e Cell Factory Centre for Transfusion Medicine   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g Cyberonics Inc   (Italy)

Author keywords

Adequacy; Anemia; Backfiltration; Biocompatibility; Hemodiafiltration; Sorbent

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; C REACTIVE PROTEIN; ESSENTIAL AMINO ACID; FERRITIN; HEMOGLOBIN; HOMOCYSTINE; INFUSION FLUID; INTERLEUKIN 6; RETINOL; SORBENT; TOCOPHEROL;

AMINO ACID BLOOD LEVEL; ANEMIA; BIOCOMPATIBILITY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMODIALYSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NUTRITIONAL STATUS; RANDOMIZED CONTROLLED TRIAL; REVIEW; UREMIA; VITAMIN BLOOD LEVEL;

EID: 0034017533     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Vanholder R, De Smet R, Vogeleere P, et al. The uraemic syndrome. In: Jacobs CM, Kjellstrand KM, Koch KM, Winchester JF, eds. Replacement of renal function by dialysis 4th Ed. Kluwer Academic Publishers, 1996; 1-33.
2. Cerulli N, Politi L, D'Angelo AR, Scandurra R. A purification method by uncoated charcoal. Adv Exp Med Biol 1987; 223: 193-6.
3. Ghezzi PM, Frigato G, Fantini GF, et al. Theoretical model and first clinical results of paired filtration dialysis. Life Support Syst 1983; (suppl 1): S271-5.
4. Ghezzi PM, Gervasio R, Tessore V, et al. Hemodiafiltration without replacement fluid. ASAIO J 1992; 38: 61-5.
5. De Francisco ALM, BotellaJ, Escallada R, et al. Hemodiafltration with sorbent-regenerated ultrafltrate as replacement fluid: a multicenter study. Nephrol Dial Transplant 1997; 12: 528-34.
6. Dunea G, Kolff WJ. Clinical experience with the Yatzidis charcoal artifcial kidney. Trans Am Soc Artif Intern Organs 1965; 2: 178-2.
7. Shaldon S, Beau MC, Carlet G, et al. Sorbent regeneration of ultrafltrate as long term treatment of end stage renal failure. Nephrol Dial Transplant 1978; 12: 708-11.
8. Pierides AM, Frohnert PP. Aluminum related dialysis osteomalacia and dementia after prolonged use of the Redy cartridge (abstract). ASAIO J 1981; 10: 53.
9. Ash SR. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs 1994; 18: 355-62.
10. Yatzidis H. The use of ion exchange resins and charcoal in acute barbiturate poisoning. In: Matthew H, ed. Acute barbiturate poisoning. Amsterdam: Excerpta Medica, 1971; 223-32.
11. Yatzidis H, Yulis G, Digenis P. Hemocarboperfusion hemodialysis treatment in terminal renal failure. Kidney Int 1976; 10: 312-4.
12. Tetta C, Cavaillon JM, Schultze M, Ronco C, Ghezzi PM, Camussi G, Serra AM, Curti F, Lonnemann G. Removal of cytokines and activated complement components in an experimental model of continuous plasmafiltration coupled with sorbent adsorption. Nephrol Dial Transplant 1998; 13: 1458-64.
13. Ronco C, Brendolan A, Feriani M, Milan M, Conz P, Lupi A, Berto P, Bettini M, La Greca G. A new scintigraphic method to characterize ultrafiltration in hollow fiber dialyzers. Kidney Int 1992; 41: 1383-93.
14. Botella J, La Greca G, Klinkmann H, Tetta C, Zucchelli P. Chronic inflammation in haemodialysis. Blood Purif (suppl.): 2000 (in press).
15. Panichi V, De Pietro S, Andreini B, Migliori M, Tessore V, Taccola D, Rindi P, Palla R, Tetta C. Cytokine production in hemodiafiltration: a multicentre study. Nephrol Dial Transplant 1998; 13: 1737-44.
16. Schindler R, Serovka F, Frei U. Transport mechanisms of cytokine-inducing substances through hemodialyzers (abstract A1159). Am Soc Nephrol 1997; 8: 252A.
17. Panichi V, Tetta C, Rindi P, Palla R, Lonnemann G. Plasma C reactive protein is linked to backfltration associated interleukin-6 production. ASAIO J 1998; 44: M415-7.
18. Panichi V, Migliori M, De Pietro S, Metelli MP, Taccola D, Perez R, Palla R, Rindi P, Cristofani R, Tetta C. Plasma C-reactive protein in hemodialysis patients: a cross-sectional longitudinal clinical survey. Blood Purif 2000; 18: 30-36.
19. Carozzi S, Nasini MG, Santoni O, Rotta A, Sanna A. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired fltration dialysis. ASAIO J 1997; 43: M535-8.
20. Bonforte G, Beretta M, Baj A, et al. Anemia and hemodiafiltration with on-line production of infusion fluid. Nephrol Dial Transplant 1997; 12: A168.
21. Maduell F, del Pozo C, Garcia H, et al. Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 1999; 14: 1202-7.
22. Eiselt J, Opatrny K, Sefrna F, et al. The effect of acetate-free biofiltration on anemia and use of erythropoietin. Cas Lek Cesk 1997; 21; 135: 525-9.
23. Meinero S, Canepari G, Giorgi MP, Moggia E, Guarneri A, Ghezzi PM. Eritropoietina in dialisi: analisi dei risultati ed impatto economico del trattamento. In: Perché, Come, Quando? Nefrologia Dialisi e Trapianto '94, Milano: Wichtig Editore, 175-9.
24. Cristol JP, Canaud B, Rabesandratana H, et al. Enhancement of reactive oxygen species production and cell surface markers expression during hemodialysis. Nephrol Dial Transplant 1994; 9: 389-94.
25. Tetta C, Biasioli S, Schiavon R, Inguaggiato P, David S, Panichi V, Wratten ML. An overview of hemodialysis and oxidative stress. Blood Purif 1999; 17: 64-72.
26. Takahashi K, Newburger PE, Cohen HJ. Glutathione peroxidase protein absence in selenium deficiency and correlation with enzymatic activity. J Clin Invest 1986; 77: 1402-4.
27. Sullivan JF, Eisenstein AB. Ascorbic acid depletion in patients undergoing hemodialysis. Am J Clin Nutr 1970; 23: 1339-146.
28. Descombes E, Hanck AB, Fellay G. Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int 1993; 43: 19-28.
29. Van Wyck DB, Stivelman JC, RuizJ, Kirlin LF, Katz MA, Ogden DA. Iron status in patients receiving erythropoietin for dialysis associated anemia. Kidney Int 1989; 35: 712-6.
30. Canavese C. Ferro e Felicita. EdiSES, Napoli 1998.